Project Grant W81XWH2110285

Award Date 6/1/21
Completion Date 5/31/23
Dollars Obligated $320K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The Department of the Army Medical Command awarded Baylor College of Medicine a $320,000 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period of March 1, 2022 through February 29, 2024. The grant will support research into the anti-fibrotic effects of macropinocytosis inhibition in idiopathic pulmonary fibrosis. Through the Military Medical Research and Development program, the Department of the Army aims to transform military and public health...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
The Department of the Army Medical Command awarded a $1,419,356 project grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop novel immunotherapy approaches to suppress cancer metastasis and recurrence in bone. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The U.S. Department of Defense's Defense Health Agency awarded a $323,000 Project Grant with a performance period from March 1, 2024 to February 28, 2026 to The Methodist Hospital Research Institute Division. This grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to identify cardiac conduction system abnormalities in a myotonic dystrophy animal model using noninvasive techniques. The Methodist Hospital Research Institute has a track record...
The Department of the Army Medical Command awarded an $8.2 million cooperative agreement to the University of Utah from August 1, 2022 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). The award will support the prevention of lethal metastatic breast cancer by identifying and eradicating clinically relevant disseminated tumor cells. A $1.5 million subaward was provided to the University Health Network in Toronto, Canada to support related research...
The Department of Defense's Defense Health Agency awarded a $444,125 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Methodist Hospital Research Institute (HMRI) in Houston, Texas. The grant, titled "IDENTIFICATION OF LIAX BINDING PARTNERS FOR PREVENTING RESISTANCE", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on...
This $1,200,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to eliminate bone metastasis through a bone-targeting E-cadherin antibody nanogel. The 4-year award, effective from April 1, 2025 to March 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. As a leading academic medical...
The Department of the Army Medical Command awarded Baylor College of Medicine a $10,087,552 project grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2026. The grant funds research on combinatorial helper-dependent adenoviral gene therapy for post-traumatic osteoarthritis. Specifically, Baylor College of Medicine and sub-awardees Cornell University ($401,517 each) will conduct preclinical studies to assess the prevention...
The federal Project Grant award of $1,496,576.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at Baylor College of Medicine in Houston, Texas, aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational domains, will focus on innovative investigations across multiple medical...
The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...

The Department of the Army Medical Command awarded The Methodist Hospital Research Institute $319,669 under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2021 through May 31, 2023. The project aims to investigate novel M2 lipogenic macrophages associated with fracture callus that are altered in type 2 diabetes. Baylor College of Medicine will serve as a sub-awardee to assist with the research. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program seeks to transform health care for service members and the public by investigating medical solutions for the battlefield. This award will further those goals by exploring changes to macrophages during bone healing among those with diabetes.

Generated 1/7/24, 9:44 AM